We are live on ! Find out more
CNST

Constellation Pharmaceuticals, Inc.
CNST

Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of CNST yet.

CNST Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2021, worth a combined $0 — down 100% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of CNST and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $108M sold.

  • 0 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2021, down from 153 in Q2 2021.
  • Funds reported $0 of Constellation Pharmaceuticals, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2021 and 153 closed out, a net change of -153 holders.
  • The largest Constellation Pharmaceuticals, Inc. seller in Q3 2021 was Avoro Capital Advisors, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2021.